Athanor Capital, LP Bridge Bio Pharma, Inc. Transaction History

Athanor Capital, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$46.47 - $63.93 $238,437 - $328,024	-5,131 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$55.47 - $72.35 $488,635 - $637,331	-8,809 Reduced 63.19%	5,131 $316,000
Q4 2020 Feb 16, 2021	SELL	$38.38 - $71.11 $214,697 - $397,789	-5,594 Reduced 28.64%	13,940 $991,000
Q3 2020 Nov 16, 2020	SELL	$27.2 - $42.19 $256,332 - $397,598	-9,424 Reduced 32.54%	19,534 $733,000
Q2 2020 Aug 13, 2020	BUY	$22.22 - $35.69 $643,446 - $1.03 Million	28,958 New	28,958 $944,000
Q1 2020 May 14, 2020	SELL	$16.11 - $36.23 $568,409 - $1.28 Million	-35,283 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$17.96 - $46.63 $29,903 - $77,638	-1,665 Reduced 4.51%	35,283 $1.24 Million
Q3 2019 Nov 14, 2019	BUY	$20.13 - $32.38 $743,763 - $1.2 Million	36,948 New	36,948 $793,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.47B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.